tlooto
Sign up
Histone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsCatalytic C–H Functionalization Methods

Exploring new quinoxaline, quinoline, and naphthalene carboxamides as HDAC-targeted anticancer agents: Cytotoxicity, enzymatic HDAC evaluation, and in silico studies

Jariya Jampahom, Jiratthakan Prathumchat, S. Pitchuanchom, Chadaporn Leerat, Narissara Namwan, T. Senawong, J. Yahuafai, K. Kanokmedhakul, C. Phaosiri, M. Nontakitticharoen

2026.5.28MEDICINAL CHEMISTRY RESEARCH

DOI: 10.1007/s00044-026-03578-7

Abstract

Abstract is not available.

Citation format

JAMPAHOM, Jariya, et al. Exploring new quinoxaline, quinoline, and naphthalene carboxamides as HDAC-targeted anticancer agents: Cytotoxicity, enzymatic HDAC evaluation, and in silico studies. MEDICINAL CHEMISTRY RESEARCH, 2026, 35(6): 1201–1221.